To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone



Status:Completed
Conditions:Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:21 - 60
Updated:4/21/2016
Start Date:June 2008
End Date:August 2009

Use our guide to learn which trials are right for you!

A Randomized, Open-Label, Fixed Dose, Active-Control, Multi-Center Phase IIB Study to Evaluate Fertility in Men With Secondary Hypogonadism, Comparing Androxal® to a Topical Testosterone in Men Previously Treated With Topical Testosterone.

The study was designed to determine if Androxal® would affect sperm parameters (count,
concentration, volume) in men with secondary hypogonadism who have been previously treated
with topical testosterone.

The study was designed to determine if Androxal® would affect sperm parameters (count,
concentration, volume) in men with secondary hypogonadism who have been previously treated
with topical testosterone. A maximum of twelve subjects per group were randomized to daily
treatments of Androxal® or topical testosterone (Testim®) for six months. The protocol was
later amended to include a treatment group who received Androxal after a 3 month wash out
period.

Inclusion Criteria:

- Healthy adult males between 21 and 60 years of age who have been diagnosed with AIHH.

- Subjects must have been treated with a topical testosterone replacement therapy
(typically AndroGel® or Testim®) for at least 6 months at enrollment and for not more
than 2 years.

Exclusion Criteria:

- A history of idiopathic infertility due to primary hypogonadism, testicular failure,
Kallmann's syndrome or any other infertility condition.

- Subjects demonstrating any clinically significant medical condition rendering the
subjects infertile or marginally fertile other than AIHH.

- Men with a history of, known, or suspected prostate disease not ruled out by a
prostate biopsy, or a prostate specific antigen (PSA)>3.6 or clinical suspicion of
current prostate disease.

- Men with a hematocrit in excess of 50 % or hemoglobin >17 g/dl
We found this trial at
2
sites
New York, New York 10016
?
mi
from
New York, NY
Click here to add this to my saved trials
Purchase, New York 10577
?
mi
from
Purchase, NY
Click here to add this to my saved trials